Polyresistant malaria in Gurkha soldiers returning from Papua New Guinea: treatment and prevention.
Two company strength exercises to Papua New Guinea produced 21 malaria casualties of whom 16 had potentially fatal falciparum infections. The chemotherapy and prevention of polyresistant malaria from Papua New Guinea and the threat posed to the Hong Kong environment regarding malaria re-introduction are discussed.
D000962:Antimalarials / Q000627:therapeutic use*; D002738:Chloroquine / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D005006:Ethnicity; D006723:Hong Kong; D006801:Humans; D008288:Malaria / Q000188:drug therapy* / Q000517:prevention & control; D008297:Male; D008889:Military Personnel; D009390:Nepal / Q000208:ethnology; D010118:Oxytetracycline / Q000627:therapeutic use; D010219:Papua New Guinea; D010963:Plasmodium falciparum / Q000187:drug effects; D010966:Plasmodium vivax / Q000187:drug effects; D011319:Primaquine / Q000627:therapeutic use; D002727:Proguanil / Q000627:therapeutic use; D011803:Quinine / Q000627:therapeutic use; D006113:United Kingdom
D000962:Antimalarials; D002738:Chloroquine; D011803:Quinine; D011319:Primaquine; D002727:Proguanil; D010118:Oxytetracycline